lansoprazole has been researched along with Colonic Diseases in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitagawa, T | 1 |
| Sato, K | 1 |
| Yokouchi, Y | 1 |
| Tominaga, K | 1 |
| Ito, S | 1 |
| Maetani, I | 1 |
1 other study available for lansoprazole and Colonic Diseases
| Article | Year |
|---|---|
A case of lansoprazole-associated collagenous colitis with longitudinal ulcer.
Topics: Aged; Anti-Ulcer Agents; Biopsy; Colitis, Collagenous; Colitis, Ischemic; Colon; Colonic Diseases; C | 2013 |